216 related articles for article (PubMed ID: 27443634)
21. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment.
Downie FP; Mar Fan HG; Houédé-Tchen N; Yi Q; Tannock IF
Psychooncology; 2006 Oct; 15(10):921-30. PubMed ID: 16477674
[TBL] [Abstract][Full Text] [Related]
22. Quality-of-life outcomes for adjuvant chemotherapy in early-stage non-small-cell lung cancer: results from a randomized trial, JBR.10.
Bezjak A; Lee CW; Ding K; Brundage M; Winton T; Graham B; Whitehead M; Johnson DH; Livingston RB; Seymour L; Shepherd FA
J Clin Oncol; 2008 Nov; 26(31):5052-9. PubMed ID: 18809617
[TBL] [Abstract][Full Text] [Related]
23. High symptom burden is associated with impaired quality of life in colorectal cancer patients during chemotherapy:A prospective longitudinal study.
Röhrl K; Guren MG; Astrup GL; Småstuen MC; Rustøen T
Eur J Oncol Nurs; 2020 Feb; 44():101679. PubMed ID: 31751848
[TBL] [Abstract][Full Text] [Related]
24. Fatigue and other variables during adjuvant chemotherapy for colon and rectal cancer.
Berger AM; Grem JL; Visovsky C; Marunda HA; Yurkovich JM
Oncol Nurs Forum; 2010 Nov; 37(6):E359-69. PubMed ID: 21059569
[TBL] [Abstract][Full Text] [Related]
25. Associations between plasma insulin-like growth factor proteins and C-peptide and quality of life in patients with metastatic colorectal cancer.
Meyerhardt JA; Sloan JA; Sargent DJ; Goldberg RM; Pollak M; Morton RF; Ramanathan RK; Williamson SK; Findlay BP; Fuchs CS
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1402-10. PubMed ID: 15941948
[TBL] [Abstract][Full Text] [Related]
26. Physical function and quality of life in frail and/or elderly patients with metastatic colorectal cancer treated with capecitabine and bevacizumab: an exploratory analysis.
Ward P; Hecht JR; Wang HJ; Dichmann R; Liem AK; Chan D; Patel R; Hu EH; Tchekmedyian NS; Wainberg ZA; Naeim A
J Geriatr Oncol; 2014 Oct; 5(4):368-75. PubMed ID: 25002322
[TBL] [Abstract][Full Text] [Related]
27. [European Organization for Research and Treatment of Cancer QLQ-C30 and functional assessment of cancer therapy- general for measurement of quality of life in colorectal cancer patients who received adjuvant chemotherapy- a comparison].
Tsunoda A
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1719-24. PubMed ID: 20841934
[TBL] [Abstract][Full Text] [Related]
28. The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study.
Shilling V; Jenkins V; Morris R; Deutsch G; Bloomfield D
Breast; 2005 Apr; 14(2):142-50. PubMed ID: 15767184
[TBL] [Abstract][Full Text] [Related]
29. Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study.
Tsuruta A; Yamashita K; Tanioka H; Tsuji A; Inukai M; Yamakawa T; Yamatsuji T; Yoshimitsu M; Toyota K; Yamano T; Nagasaka T; Okajima M
Drug Des Devel Ther; 2016; 10():3827-3835. PubMed ID: 27920498
[TBL] [Abstract][Full Text] [Related]
30. Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapy.
Keefe DM; Elting LS; Nguyen HT; Grunberg SM; Aprile G; Bonaventura A; Selva-Nayagam S; Barsevick A; Koczwara B; Sonis ST
Cancer Chemother Pharmacol; 2014 Oct; 74(4):675-80. PubMed ID: 25055935
[TBL] [Abstract][Full Text] [Related]
31. Quality of life in colorectal cancer patients during chemotherapy in the era of monoclonal antibody therapies.
Teker F; Demirag G; Erdem D; Kemal Y; Yucel I
J BUON; 2015; 20(2):443-51. PubMed ID: 26011334
[TBL] [Abstract][Full Text] [Related]
32. High body mass index is associated with worse quality of life in breast cancer patients receiving radiotherapy.
Fang P; Tan KS; Troxel AB; Rengan R; Freedman G; Lin LL
Breast Cancer Res Treat; 2013 Aug; 141(1):125-33. PubMed ID: 23942874
[TBL] [Abstract][Full Text] [Related]
33. Menopausal symptoms in women undergoing chemotherapy-induced and natural menopause: a prospective controlled study.
Mar Fan HG; Houédé-Tchen N; Chemerynsky I; Yi QL; Xu W; Harvey B; Tannock IF
Ann Oncol; 2010 May; 21(5):983-7. PubMed ID: 19828559
[TBL] [Abstract][Full Text] [Related]
34. Investigation of the relationship among fatigue, self-efficacy and quality of life during chemotherapy in patients with breast, lung or gastrointestinal cancer.
Akin S; Kas Guner C
Eur J Cancer Care (Engl); 2019 Jan; 28(1):e12898. PubMed ID: 30039883
[TBL] [Abstract][Full Text] [Related]
35. Longitudinal quality of life and quality adjusted survival in a randomised controlled trial comparing six months of bolus fluorouracil/leucovorin vs. twelve weeks of protracted venous infusion fluorouracil as adjuvant chemotherapy for colorectal cancer.
Chau I; Norman AR; Cunningham D; Iveson T; Hill M; Hickish T; Lofts F; Jodrell D; Webb A; Tait D; Ross PJ; Shellito P; Oates JR
Eur J Cancer; 2005 Jul; 41(11):1551-9. PubMed ID: 16026692
[TBL] [Abstract][Full Text] [Related]
36. Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study.
Antonuzzo L; Giommoni E; Pastorelli D; Latiano T; Pavese I; Azzarello D; Aieta M; Pastina I; Di Fabio F; Bertolini A; Corsi DC; Mogavero S; Angelini V; Pazzagli M; Di Costanzo F
World J Gastroenterol; 2015 Jun; 21(23):7281-8. PubMed ID: 26109816
[TBL] [Abstract][Full Text] [Related]
37. The trajectory of fatigue in adult patients with breast and ovarian cancer receiving chemotherapy.
Payne JK
Oncol Nurs Forum; 2002 Oct; 29(9):1334-40. PubMed ID: 12370703
[TBL] [Abstract][Full Text] [Related]
38. Does quality of life return to pre-treatment levels five years after curative intent surgery for colorectal cancer? Evidence from the ColoREctal Wellbeing (CREW) study.
Wheelwright S; Permyakova NV; Calman L; Din A; Fenlon D; Richardson A; Sodergren S; Smith PWF; Winter J; Foster C;
PLoS One; 2020; 15(4):e0231332. PubMed ID: 32271835
[TBL] [Abstract][Full Text] [Related]
39. Correlation between hemoglobin and fatigue in women undergoing adjuvant chemotherapy without erythropoietin-stimulating-agent support.
Blair S; Bardwell WA; Podbelewicz-Schuller Y; Mortimer JE
Clin Breast Cancer; 2008 Dec; 8(6):522-6. PubMed ID: 19073508
[TBL] [Abstract][Full Text] [Related]
40. Geriatric Assessment Predicts Survival and Competing Mortality in Elderly Patients with Early Colorectal Cancer: Can It Help in Adjuvant Therapy Decision-Making?
Antonio M; Saldaña J; Carmona-Bayonas A; Navarro V; Tebé C; Nadal M; Formiga F; Salazar R; Borràs JM
Oncologist; 2017 Aug; 22(8):934-943. PubMed ID: 28487465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
